TELA Bio amends 8-K to detail former CEO Koblish separation benefits

Reuters2026/08/13 20:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

TELA Bio amended a prior 8-K to add details of a separation agreement with former CEO Antony Koblish, effective Aug. 7.
Agreement provides 12 months of base-salary severance, paid in installments, covering the period following his Aug. 3 exit.
All equity awards immediately accelerated to full vesting; option exercise window extended to the earlier of Dec. 31, 2027 or expiry.
COBRA coverage available through Aug. 31; company to pay premiums for 12 months if elected by Sept. 1.
Performance stock units remain eligible to vest through Dec. 31, 2026, with target vesting on a change in control by then.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-095892), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

TELA Bio amends 8-K to detail former CEO Koblish separation benefits

You may also like

Crypto prices